MADISON KEARNEY: Open Payments
NPI 1083355986 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,965 in 89 payments from 15 companies in 2025. Trend: 2023 $1,968 · 2024 $2,552 · 2025 $1,965
Food & beverage: $1,965
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $402 |
| Lilly USA, LLC | 9 | $238 |
| Novartis Pharmaceuticals Corporation | 11 | $225 |
| Incyte Corporation | 9 | $218 |
| Arcutis Biotherapeutics, Inc. | 16 | $212 |
| LEO Pharma Inc. | 11 | $193 |
| Galderma Laboratories, L.P. | 4 | $138 |
| GENZYME CORPORATION | 4 | $118 |
| Janssen Biotech, Inc. | 2 | $61 |
| ABBVIE INC. | 3 | $41 |
Products named: Bimzelx, OPZELURA, Zoryve, COSENTYX, NEMLUVIO, DUPIXENT, TALTZ, ADBRY.
Industry payments across OK — which companies pay providers there.
